SnoreStop NasoSpray — Class I drug recall D-1165-2022
Terminated recall by Green Pharmaceuticals, Inc., reported 2022-07-06, distributed nationwide. Microbial contamination of non-sterile product: FDA laboratory analysis found product to contain microbial con
| Recall number | D-1165-2022 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Green Pharmaceuticals, Inc., Camarillo, CA, United States |
| Recall initiated | 2022-06-09 |
| Classified | 2022-06-27 |
| Reported by FDA | 2022-07-06 |
| Terminated | 2023-04-14 |
| Distributed | Nationwide (US) |
| Quantity | 1,074 spray |
| Reason classes | microbial contamination, sterility |
| UPC / GTIN / UDI-DI | 00769682291013 |
| NDC | 61152-0199-99 |
| Lot numbers | 2373/21222 |
Product
SnoreStop NasoSpray, 0.3 FL OZ (9 mL), Green Pharmaceuticals Inc. Camarillo, CA 93012, NDC 61152-199-99, UPC 7 69682 29101 3
Reason for recall
Microbial contamination of non-sterile product: FDA laboratory analysis found product to contain microbial contamination identified as Providencia rettgeri.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1165-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.